What does Vericel Corp. do?

Jun 22 2025 06:16 PM IST
share
Share Via
Vericel Corporation is a biopharmaceutical company focused on developing therapies for tissue and organ repair. As of March 2025, it reported net sales of $53 million and a net loss of $11 million, with a market cap of approximately $2.09 billion.
Overview:
Vericel Corporation is an integrated, commercial-stage biopharmaceutical company dedicated to the identification, development, and commercialization of therapies that enable the body to repair and regenerate damaged tissues and organs, operating in the Pharmaceuticals & Biotechnology industry with a small-cap market classification. Financial Snapshot: Most recent Net Sales: 53 Million (Quarterly Results - Mar 2025) Most recent Net Profit: -11 Million (Quarterly Results - Mar 2025) Market-cap: USD 2,089.23 Million (Small Cap) Key Metrics: P/E: 732.00 Dividend Yield: 0.00% Debt Equity: -0.36 Return on Equity: 1.01% Price to Book: 7.07 Contact Details: Address: 64 Sidney St, CAMBRIDGE MA : 02139-4170 Tel: 1 734 9305555 Website: https://vcel.com/
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News